{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:58:08Z","timestamp":1790621888047,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,2]]},"DOI":"10.7759\/cureus.37037","type":"journal-article","created":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T18:07:56Z","timestamp":1680458876000},"source":"Crossref","is-referenced-by-count":7,"title":["Peyronie\u2019s Disease: A Brief Overview"],"prefix":"10.7759","author":[{"given":"Oladapo","family":"Feyisetan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)65361-8","article-title":"Proposal: trauma as the cause of the Peyronie\u2019s lesion","volume":"157","author":"Devine CJ Jr","year":"1997","unstructured":"Devine CJ Jr, Somers KD, Jordan SG, Schlossberg SM. Proposal: trauma as the cause of the Peyronie\u2019s lesion. J Urol. 1997, 157:285-90. 10.1016\/S0022-5347(01)65361-8","journal-title":"J Urol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3900875","article-title":"Pathophysiology of Peyronie\u2019s disease","volume":"14","author":"Moreland RB","year":"2002","unstructured":"Moreland RB, Nehra A. Pathophysiology of Peyronie\u2019s disease. Int J Impot Res. 2002, 14:406-10. 10.1038\/sj.ijir.3900875","journal-title":"Int J Impot Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-4096.2001.02436.x","article-title":"The prevalence of Peyronie's disease: results of a large survey","volume":"88","author":"Schwarzer U","year":"2001","unstructured":"Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie's disease: results of a large survey. BJU Int. 2001, 88:727-30. 10.1046\/j.1464-4096.2001.02436.x","journal-title":"BJU Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)37988-0","article-title":"The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984","volume":"146","author":"Lindsay MB","year":"1991","unstructured":"Lindsay MB, Schain DM, Grambsch P, Benson RC, Beard CM, Kurland LT. The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984. J Urol. 1991, 146:1009. 10.1016\/S0022-5347(17)37988-0","journal-title":"J Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14605","article-title":"Prevalence of penile curvature: a population-based cross-sectional study in metropolitan and rural cities in Australia","volume":"122 Suppl 5","author":"Chung E","year":"2018","unstructured":"Chung E, Gillman M, Rushton D, Love C, Katz D. Prevalence of penile curvature: a population-based cross-sectional study in metropolitan and rural cities in Australia. BJU Int. 2018, 122 Suppl 5:42-9. 10.1111\/bju.14605","journal-title":"BJU Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.esxm.2017.06.001","article-title":"Prevalence of Peyronie's disease-like symptoms in men presenting with Dupuytren contractures","volume":"5","author":"Shindel AW","year":"2017","unstructured":"Shindel AW, Sweet G, Thieu W, Durbin-Johnson B, Rothschild J, Szabo R. Prevalence of Peyronie's disease-like symptoms in men presenting with Dupuytren contractures. Sex Med. 2017, 5:e135-41. 10.1016\/j.esxm.2017.06.001","journal-title":"Sex Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/ijir.2011.18","article-title":"The association between Peyronie's and Dupuytren's disease","volume":"23","author":"Nugteren HM","year":"2011","unstructured":"Nugteren HM, Nijman JM, de Jong IJ, van Driel MF. The association between Peyronie's and Dupuytren's disease. Int J Impot Res. 2011, 23:142-5. 10.1038\/ijir.2011.18","journal-title":"Int J Impot Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)52751-2","article-title":"Identification of an inherited form of Peyronie\u2019s disease with autosomal dominant inheritance and association with Dupuytren\u2019s contracture and histocompatibility B7 cross-reacting antigens","volume":"128","author":"Nyberg LM","year":"1982","unstructured":"Nyberg LM, Bias WB, Hochberg MC, Walsh PC. Identification of an inherited form of Peyronie\u2019s disease with autosomal dominant inheritance and association with Dupuytren\u2019s contracture and histocompatibility B7 cross-reacting antigens. J Urol. 1982, 128:48-51. 10.1016\/S0022-5347(17)52751-2","journal-title":"J Urol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1997.12.6.929","article-title":"Peyronie's disease is associated with Paget's disease of bone","volume":"12","author":"Lyles KW","year":"1997","unstructured":"Lyles KW, Gold DT, Newton RA, et al.. Peyronie's disease is associated with Paget's disease of bone. J Bone Miner Res. 1997, 12:929-34. 10.1359\/jbmr.1997.12.6.929","journal-title":"J Bone Miner Res"},{"key":"ref10","article-title":"Peyronie disease","author":"Sandean DP","year":"2023","unstructured":"Sandean DP, Lotfollahzadeh S. Peyronie disease. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref11","article-title":"Sexual and reproductive health","author":"Salonia A","year":"2020","unstructured":"Salonia A, Bettocchi C, Carvalho J, et al.. Sexual and reproductive health. European Association of Urology, 2020."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/282503","article-title":"A population-based study of Peyronie\u2019s disease: prevalence and treatment patterns in the United States","volume":"2011","author":"Dibenedetti DB","year":"2011","unstructured":"Dibenedetti DB, Nguyen D, Zografos L, Ziemiecki R, Zhou X. A population-based study of Peyronie\u2019s disease: prevalence and treatment patterns in the United States. Adv Urol. 2011, 2011:282503. 10.1155\/2011\/282503","journal-title":"Adv Urol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3900877","article-title":"Clinical presentations of Peyronie\u2019s disease","volume":"14","author":"Pryor JP","year":"2002","unstructured":"Pryor JP, Ralph DJ. Clinical presentations of Peyronie\u2019s disease. Int J Impot Res. 2002, 14:414-17. 10.1038\/sj.ijir.3900877","journal-title":"Int J Impot Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/bju.12346","article-title":"Deformity stabilization and improvement in men with untreated Peyronie's disease","volume":"113","author":"Berookhim BM","year":"2014","unstructured":"Berookhim BM, Choi J, Alex B, Mulhall JP. Deformity stabilization and improvement in men with untreated Peyronie's disease. BJU Int. 2014, 113:133-6. 10.1111\/bju.12346","journal-title":"BJU Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)39746-x","article-title":"The natural history of Peyronie\u2019s disease","volume":"144","author":"Gelbard MK","year":"1990","unstructured":"Gelbard MK, Dorey F, James K. The natural history of Peyronie\u2019s disease. J Urol. 1990, 144:1376-9. 10.1016\/s0022-5347(17)39746-x","journal-title":"J Urol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64578-8","article-title":"A retrospective review of 307 men with Peyronie\u2019s disease","volume":"168","author":"Kadioglu A","year":"2002","unstructured":"Kadioglu A, Tefekli A, Erol B, Oktar T, Tunc M, Tellaloglu S. A retrospective review of 307 men with Peyronie\u2019s disease. J Urol. 2002, 168:1075-9. 10.1016\/S0022-5347(05)64578-8","journal-title":"J Urol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(06)00270-9","article-title":"An analysis of the natural history of Peyronie\u2019s disease","volume":"175","author":"Mulhall JP","year":"2006","unstructured":"Mulhall JP, Schiff J, Guhring P. An analysis of the natural history of Peyronie\u2019s disease. J Urol. 2006, 175:2115-18. 10.1016\/S0022-5347(06)00270-9","journal-title":"J Urol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.21037\/tau.2016.05.14","article-title":"Psychological aspects of Peyronie\u2019s disease","volume":"5","author":"Terrier JE","year":"2016","unstructured":"Terrier JE, Nelson CJ. Psychological aspects of Peyronie\u2019s disease. Trans Androl Urol. 2016, 5:290-5. 10.21037\/tau.2016.05.14","journal-title":"Trans Androl Urol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2012.02999.x","article-title":"Psychological impact of Peyronie's disease: a review","volume":"10","author":"Nelson CJ","year":"2013","unstructured":"Nelson CJ, Mulhall JP. Psychological impact of Peyronie's disease: a review. J Sex Med. 2013, 10:653-60. 10.1111\/j.1743-6109.2012.02999.x","journal-title":"J Sex Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2020.08.010","article-title":"Peyronie\u2019s disease and the female sexual partner: a comparison of the male and female experience","volume":"17","author":"Farrell MR","year":"2020","unstructured":"Farrell MR, Ziegelmann MJ, Bajic P, Levine LA. Peyronie\u2019s disease and the female sexual partner: a comparison of the male and female experience. J Sex Med. 2020, 17:2456-61. 10.1016\/j.jsxm.2020.08.010","journal-title":"J Sex Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.sxmr.2020.11.002","article-title":"Peyronie's disease: what about the female sexual partner?","volume":"9","author":"Kern T","year":"2021","unstructured":"Kern T, Ye N, Abdelsayed GA. Peyronie's disease: what about the female sexual partner?. Sex Med Rev. 2021, 9:230-5. 10.1016\/j.sxmr.2020.11.002","journal-title":"Sex Med Rev"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2016.04.074","article-title":"Female partners of men with Peyronie\u2019s disease have impaired sexual function, satisfaction, and mood, while degree of sexual interference is associated with worse outcomes","volume":"13","author":"Davis SNP","year":"2016","unstructured":"Davis SNP, Ferrar S, Sadikaj G, Gerard M, Binik YM, Carrier S. Female partners of men with Peyronie\u2019s disease have impaired sexual function, satisfaction, and mood, while degree of sexual interference is associated with worse outcomes. J Sex Med. 2016, 13:1095-103. 10.1016\/j.jsxm.2016.04.074","journal-title":"J Sex Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1080\/0092623X.2016.1147511","article-title":"Shame, catastrophizing, and negative partner responses are associated with lower sexual and relationship satisfaction and more negative affect in men with Peyronie\u2019s disease","volume":"43","author":"Davis S","year":"2017","unstructured":"Davis S, Ferrar S, Sadikaj G, Binik Y, Carrier S. Shame, catastrophizing, and negative partner responses are associated with lower sexual and relationship satisfaction and more negative affect in men with Peyronie\u2019s disease. J Sex Marital Ther. 2017, 43:264-76. 10.1080\/0092623X.2016.1147511","journal-title":"J Sex Marital Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/medsci7090096","article-title":"Medical management of Peyronie\u2019s disease: review of the clinical evidence","volume":"7","author":"Teloken P","year":"2019","unstructured":"Teloken P, Katz D. Medical management of Peyronie\u2019s disease: review of the clinical evidence. Med Sci (Basel). 2019, 7:96. 10.3390\/medsci7090096","journal-title":"Med Sci (Basel)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.5255","article-title":"2018 Canadian Urological Association guideline for Peyronie's disease and congenital penile curvature","volume":"12","author":"Bella AJ","year":"2018","unstructured":"Bella AJ, Lee JC, Grober ED, Carrier S, Benard F, Brock GB. 2018 Canadian Urological Association guideline for Peyronie's disease and congenital penile curvature. Can Urol Assoc J. 2018, 12:E197-209. 10.5489\/cuaj.5255","journal-title":"Can Urol Assoc J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2016.04.062","article-title":"Evidence-based management guidelines on Peyronie\u2019s disease","volume":"13","author":"Chung E","year":"2016","unstructured":"Chung E, Ralph D, Kagioglu A, et al.. Evidence-based management guidelines on Peyronie\u2019s disease. J Sex Med. 2016, 13:905-23. 10.1016\/j.jsxm.2016.04.062","journal-title":"J Sex Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.05.098","article-title":"Peyronie's disease: AUA guideline","volume":"194","author":"Nehra A","year":"2015","unstructured":"Nehra A, Alterowitz R, Culkin DJ, et al.. Peyronie's disease: AUA guideline. J Urol. 2015, 194:745-53. 10.1016\/j.juro.2015.05.098","journal-title":"J Urol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2010.09331.x","article-title":"Limited shock wave therapy vs sham treatment in men with Peyronie's disease: results of a prospective randomized controlled double-blind trial","volume":"106","author":"Chitale S","year":"2010","unstructured":"Chitale S, Morsey M, Swift L, Sethia K. Limited shock wave therapy vs sham treatment in men with Peyronie's disease: results of a prospective randomized controlled double-blind trial. BJU Int. 2010, 106:1352-6. 10.1111\/j.1464-410X.2010.09331.x","journal-title":"BJU Int"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.05.012","article-title":"A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease","volume":"56","author":"Palmieri A","year":"2009","unstructured":"Palmieri A, Imbimbo C, Longo N, et al.. A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease. Eur Urol. 2009, 56:363-9. 10.1016\/j.eururo.2009.05.012","journal-title":"Eur Urol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2605.2011.01226.x","article-title":"Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie's disease and erectile dysfunction: results from a prospective randomized trial","volume":"35","author":"Palmieri A","year":"2012","unstructured":"Palmieri A, Imbimbo C, Creta M, Verze P, Fusco F, Mirone V. Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie's disease and erectile dysfunction: results from a prospective randomized trial. Int J Androl. 2012, 35:190-5. 10.1111\/j.1365-2605.2011.01226.x","journal-title":"Int J Androl"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12400","article-title":"Acute phase Peyronie's disease management with traction device: a nonrandomized prospective controlled trial with ultrasound correlation","volume":"11","author":"Mart\u00ednez-Salamanca JI","year":"2014","unstructured":"Mart\u00ednez-Salamanca JI, Egui A, Moncada I, et al.. Acute phase Peyronie's disease management with traction device: a nonrandomized prospective controlled trial with ultrasound correlation. J Sex Med. 2014, 11:506-15. 10.1111\/jsm.12400","journal-title":"J Sex Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14602","article-title":"Penile traction therapy with the new device 'Penimaster PRO' is effective and safe in the stable phase of Peyronie's disease: a controlled multicentre study","volume":"123","author":"Moncada I","year":"2019","unstructured":"Moncada I, Krishnappa P, Romero J, et al.. Penile traction therapy with the new device 'Penimaster PRO' is effective and safe in the stable phase of Peyronie's disease: a controlled multicentre study. BJU Int. 2019, 123:694-702. 10.1111\/bju.14602","journal-title":"BJU Int"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2010.09365.x","article-title":"The role of vacuum pump therapy to mechanically straighten the penis in Peyronie's disease","volume":"106","author":"Raheem AA","year":"2010","unstructured":"Raheem AA, Garaffa G, Raheem TA, Dixon M, Kayes A, Christopher N, Ralph D. The role of vacuum pump therapy to mechanically straighten the penis in Peyronie's disease. BJU Int. 2010, 106:1178-80. 10.1111\/j.1464-410X.2010.09365.x","journal-title":"BJU Int"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2013.01.087","article-title":"Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies","volume":"190","author":"Gelbard M","year":"2013","unstructured":"Gelbard M, Goldstein I, Hellstrom WJ, et al.. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol. 2013, 190:199-207. 10.1016\/j.juro.2013.01.087","journal-title":"J Urol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13096","article-title":"Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie's disease by subgroup: results from two large, double-blind, randomized, placebo-controlled, phase III studies","volume":"116","author":"Lipshultz LI","year":"2015","unstructured":"Lipshultz LI, Goldstein I, Seftel AD, Kaufman GJ, Smith TM, Tursi JP, Burnett AL. Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie's disease by subgroup: results from two large, double-blind, randomized, placebo-controlled, phase III studies. BJU Int. 2015, 116:650-6. 10.1111\/bju.13096","journal-title":"BJU Int"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2017.08.015","article-title":"Treatment of Peyronie\u2019s Disease with collagenase Clostridium histolyticum and vacuum therapy: a randomized, open-label pilot study","volume":"14","author":"Ralph DJ","year":"2017","unstructured":"Ralph DJ, Abdel Raheem A, Liu G. Treatment of Peyronie\u2019s Disease with collagenase Clostridium histolyticum and vacuum therapy: a randomized, open-label pilot study. J Sex Med. 2017, 14:1430-7. 10.1016\/j.jsxm.2017.08.015","journal-title":"J Sex Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.urpr.2016.04.005","article-title":"Superior cost effectiveness of penile plication vs intralesional collagenase injection for treatment of Peyronie\u2019s disease deformities","volume":"4","author":"Cordon BH","year":"2017","unstructured":"Cordon BH, Hofer MD, Hutchinson RC, Broderick GA, Lotan Y, Morey AF. Superior cost effectiveness of penile plication vs intralesional collagenase injection for treatment of Peyronie\u2019s disease deformities. Urol Pract. 2017, 4:118-25. 10.1016\/j.urpr.2016.04.005","journal-title":"Urol Pract"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.sxmr.2017.07.005","article-title":"Collagenase Clostridium histolyticum in the treatment of Peyronie\u2019s disease - a review of the literature and a new modified protocol","volume":"5","author":"Abdel Raheem A","year":"2017","unstructured":"Abdel Raheem A, Johnson M, Abdel-Raheem T, Capece M, Ralph D. Collagenase Clostridium histolyticum in the treatment of Peyronie\u2019s disease - a review of the literature and a new modified protocol. Sex Med Rev. 2017, 5:529-35. 10.1016\/j.sxmr.2017.07.005","journal-title":"Sex Med Rev"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(06)00517-9","article-title":"Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon \u03b1-2b for minimally invasive treatment for Peyronie\u2019s disease","volume":"176","author":"Hellstrom WJ","year":"2006","unstructured":"Hellstrom WJ, Kendirci M, Matern R, et al.. Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon \u03b1-2b for minimally invasive treatment for Peyronie\u2019s disease. J Urol. 2006, 176:394-8. 10.1016\/S0022-5347(06)00517-9","journal-title":"J Urol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2005.00110.x","article-title":"The impact of intralesional interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie's disease","volume":"2","author":"Kendirci M","year":"2005","unstructured":"Kendirci M, Usta MF, Matern RV, Nowfar S, Sikka SC, Hellstrom WJ. The impact of intralesional interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie's disease. J Sex Med. 2005, 2:709-15. 10.1111\/j.1743-6109.2005.00110.x","journal-title":"J Sex Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.sxmr.2020.05.003","article-title":"Intralesional injection therapy and atypical Peyronie's disease: a systematic review","volume":"9","author":"Choi EJ","year":"2021","unstructured":"Choi EJ, Xu P, El-Khatib FM, Yafi FA. Intralesional injection therapy and atypical Peyronie's disease: a systematic review. Sex Med Rev. 2021, 9:434-44. 10.1016\/j.sxmr.2020.05.003","journal-title":"Sex Med Rev"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)63751-0","article-title":"Congenital curvature of the phallus: report of three cases with description of corrective operation","volume":"93","author":"Nesbit RM","year":"1965","unstructured":"Nesbit RM. Congenital curvature of the phallus: report of three cases with description of corrective operation. J Urol. 1965, 93:230-2. 10.1016\/s0022-5347(17)63751-0","journal-title":"J Urol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)56530-1","article-title":"A new approach to the correction of the penile deformity in Peyronie\u2019s disease","volume":"122","author":"Pryor JP","year":"1979","unstructured":"Pryor JP, Fitzpatrick JM. A new approach to the correction of the penile deformity in Peyronie\u2019s disease. J Urol. 1979, 122:622-3. 10.1016\/s0022-5347(17)56530-1","journal-title":"J Urol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.21037\/tau.2018.04.06","article-title":"Contemporary surgical and non-surgical management of Peyronie\u2019s disease","volume":"7","author":"Wayne GF","year":"2018","unstructured":"Wayne GF, Cordon BH. Contemporary surgical and non-surgical management of Peyronie\u2019s disease. Trans Androl Urol. 2018, 7:603-17. 10.21037\/tau.2018.04.06","journal-title":"Trans Androl Urol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(01)66862-9","article-title":"Nesbit operation for Peyronie\u2019s disease: 16-year experience","volume":"154","author":"Ralph DJ","year":"1995","unstructured":"Ralph DJ, Al-Akraa M, Pryor JP. Nesbit operation for Peyronie\u2019s disease: 16-year experience. J Urol. 1995, 154:1362-3. 10.1016\/s0022-5347(01)66862-9","journal-title":"J Urol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)68184-9","article-title":"A surgical algorithm for the treatment of Peyronie\u2019s disease","volume":"158","author":"Levine LA","year":"1997","unstructured":"Levine LA, Lenting EL. A surgical algorithm for the treatment of Peyronie\u2019s disease. J Urol. 1997, 158:2149-52. 10.1016\/S0022-5347(01)68184-9","journal-title":"J Urol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2005.20113.x","article-title":"A surgical algorithm for men with combined Peyronie's disease and erectile dysfunction: functional and satisfaction outcomes","volume":"2","author":"Mulhall J","year":"2005","unstructured":"Mulhall J, Anderson M, Parker M. A surgical algorithm for men with combined Peyronie's disease and erectile dysfunction: functional and satisfaction outcomes. J Sex Med. 2005, 2:132-8. 10.1111\/j.1743-6109.2005.20113.x","journal-title":"J Sex Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2010.01850.x","article-title":"The management of Peyronie's disease: evidence-based 2010 guidelines","volume":"7","author":"Ralph D","year":"2010","unstructured":"Ralph D, Gonzalez-Cadavid N, Mirone V, Perovic S, Sohn M, Usta M, Levine L. The management of Peyronie's disease: evidence-based 2010 guidelines. J Sex Med. 2010, 7:2359-74. 10.1111\/j.1743-6109.2010.01850.x","journal-title":"J Sex Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1038\/aja.2011.42","article-title":"Long-term results of the surgical treatment of Peyronie's disease with Egydio's technique: a European multicentre study","volume":"13","author":"Sansalone S","year":"2011","unstructured":"Sansalone S, Garaffa G, Djinovic R, et al.. Long-term results of the surgical treatment of Peyronie's disease with Egydio's technique: a European multicentre study. Asian J Androl. 2011, 13:842-5. 10.1038\/aja.2011.42","journal-title":"Asian J Androl"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.esxm.2019.01.001","article-title":"Twenty years of plaque incision and grafting for Peyronie's disease: a review of literature","volume":"7","author":"Rice PG","year":"2019","unstructured":"Rice PG, Somani BK, Rees RW. Twenty years of plaque incision and grafting for Peyronie's disease: a review of literature. Sex Med. 2019, 7:115-28. 10.1016\/j.esxm.2019.01.001","journal-title":"Sex Med"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2010.02102.x","article-title":"Five-year follow-up of Peyronie's graft surgery: outcomes and patient satisfaction","volume":"8","author":"Chung E","year":"2011","unstructured":"Chung E, Clendinning E, Lessard L, Brock G. Five-year follow-up of Peyronie's graft surgery: outcomes and patient satisfaction. J Sex Med. 2011, 8:594-600. 10.1111\/j.1743-6109.2010.02102.x","journal-title":"J Sex Med"},{"key":"ref52","article-title":"Surgical treatment of erectile dysfunction and Peyronie's disease using malleable prosthesis","volume":"12","author":"Yavuz U","year":"2015","unstructured":"Yavuz U, Ciftci S, Ustuner M, Yilmaz H, Culha M. Surgical treatment of erectile dysfunction and Peyronie's disease using malleable prosthesis. Urol J. 2015, 12:2428-33.","journal-title":"Urol J"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.esxm.2017.10.004","article-title":"Malleable penile implant is an effective therapeutic option in men with Peyronie's disease and erectile dysfunction","volume":"6","author":"Habous M","year":"2018","unstructured":"Habous M, Tealab A, Farag M, et al.. Malleable penile implant is an effective therapeutic option in men with Peyronie's disease and erectile dysfunction. Sex Med. 2018, 6:24-9. 10.1016\/j.esxm.2017.10.004","journal-title":"Sex Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/140766-peyronies-disease-a-brief-overview","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:48Z","timestamp":1707508548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/140766-peyronies-disease-a-brief-overview"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,2]]},"references-count":53,"URL":"https:\/\/doi.org\/10.7759\/cureus.37037","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,2]]}}}